/term/common-stock/STU:4XB XBiotech (STU:4XB) Common Stock
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Common Stock

XBiotech (STU:4XB) Common Stock : €249.86 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is XBiotech Common Stock?

XBiotech's quarterly common stock declined from Sep. 2023 (€252.89 Mil) to Dec. 2023 (€248.65 Mil) but then increased from Dec. 2023 (€248.65 Mil) to Mar. 2024 (€249.86 Mil).

XBiotech's annual common stock increased from Dec. 2021 (€232.10 Mil) to Dec. 2022 (€252.36 Mil) but then declined from Dec. 2022 (€252.36 Mil) to Dec. 2023 (€248.65 Mil).


XBiotech Common Stock Historical Data

The historical data trend for XBiotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XBiotech Common Stock Chart

XBiotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 292.33 205.34 232.10 252.36 248.65

XBiotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 250.34 248.22 252.89 248.65 249.86

XBiotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


XBiotech (STU:4XB) Business Description

Traded in Other Exchanges
Address
5217 Winnebago Lane, Austin, TX, USA, 78744
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

XBiotech (STU:4XB) Headlines

No Headlines